ImmunityBio
A Senior Manager, Quality Control Microbiology at ImmunityBio leads the QC microbiology function supporting early-phase clinical and commercial biologics manufacturing across internal and partner sites. The role provides strategic oversight to ensure microbiology activities and programs align with regulatory expectations and company quality standards.
Headquarters
San Diego, California, United States
Company Size
501-1000 employees
Founded
2014
We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.
ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data
3 days ago
Is It Time To Reassess ImmunityBio (IBRX) After Its Recent Share Price Surge
2 days ago
ImmunityBio’s Stock Sees a Huge Boost
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ImmunityBio.
ImmunityBio (NASDAQ:IBRX) Stock Price Up 3.2% - What's Next?
1 day ago
Lead QC Microbiology
Denali Therapeutics
QC Microbiology Associate Scientist
WuXi Biologics
Supervisor, Microbiology Quality Control
Bio-Techne
Manager/Senior Manager, Quality Control - Microbiology
Genezen
Director, Quality Control Microbiology
Resilience
Microbiology & Sterility Assurance Manager
Cardinal Health